Kristen Pierce

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Andrew Kucharchuk, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristen Pierce:

Company Role Class Num Shares Value Price $ Report Date Ownership
CERO THERAPEUTICS HOLDINGS, INC. Chief Development Officer Stock Option (Right to Buy) 1,612,099 07 Jan 2026 Direct

Insider Reports Filed by Kristen Pierce

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CERO CERO THERAPEUTICS HOLDINGS, INC. 07 Jan 2026 1 $0 4 Chief Development Officer 09 Jan 2026, 16:30
CERO CERO THERAPEUTICS HOLDINGS, INC. 30 May 2025 1 $0 4 Chief Development Officer 02 Jun 2025, 17:01
CERO CERO THERAPEUTICS HOLDINGS, INC. 01 Oct 2024 0 $0 3/A Chief Development Officer 08 May 2025, 06:11
CERO CERO THERAPEUTICS HOLDINGS, INC. 01 Oct 2024 1 $0 4 Chief Development Officer 02 Oct 2024, 19:02